Progress on plague vaccine development

Applied Microbiology and Biotechnology

Volumn 91, Issue 2, 2011, Pages 265-286

  Rosenzweig, Jason A ^a   Jejelowo, Olufisayo ^a   Sha, Jian ^b   Erova, Tatiana E ^b   Brackman, Sheri M ^b   Kirtley, Michelle L ^b   Van Lier, Cristina J ^b   Chopra, Ashok K ^b,c  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Bubonic; Plague; Pneumonic plague; Septicemic; Vaccine; Yersinia pestis

Indexed keywords

BUBONIC; PLAGUE; PNEUMONIC PLAGUE; SEPTICEMIC; YERSINIA PESTIS;

VACCINES;

AMPICILLIN; DNA VACCINE; F1 ANTIGEN VACCINE; F1 LCRV FUSION ANTIGEN VACCINE; GENTAMICIN; LCRV ANTIGEN VACCINE; LEVOFLOXACIN; LIVE VACCINE; PLAGUE VACCINE; QUINOLONE DERIVATIVE; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

BACTERIAL DISEASE; BACTERIUM; BLOOD; DISEASE PREVALENCE; MORTALITY; PATHOGENICITY; PNEUMONIA; RESPIRATION; VACCINATION;

ADENOVIRUS; ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; DISEASE MODEL; GENE ACTIVITY; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; NONHUMAN; PANDEMIC; PLAGUE; RACOON POX VIRUS; REVIEW; VACCINIA VIRUS; VIRUS; YERSINIA PESTIS;

ANIMALS; BIOMEDICAL RESEARCH; BIOTERRORISM; GUINEA PIGS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLAGUE; PLAGUE VACCINE; YERSINIA PESTIS;

UNITED STATES;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; RODENTIA; SIPHONAPTERA (FLEAS); YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 79960740080     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-011-3380-6     Document Type: Review

References (166)

1. M Achtman K Zurth G Morelli GA TorreaG E Carniel 1999 Yersina pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis Proc Natl Acad Sci USA 96 14043 14048 1:CAS:528:DyaK1MXns1Oqu7g%3D
2. SL Agar J Sha SM Foltz TE Erova KG Walberg TE Parham WB Baze G Suarez JW Peterson AK Chopra 2008 Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92 Microbiology 154 1939 1948 1:CAS:528:DC%2BD1cXovFartb8%3D
3. SL Agar J Sha WB Baze TE Erova SM Foltz G Suarez S Wang AK Chopra 2009 Deletion of Braun lipoprotein gene (lpp) and curing of plasmid pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague Microbiology 155 3247 3259 1:CAS:528:DC%2BD1MXhtlenur3K
4. SL Agar J Sha SM Foltz TE Erova KG Walberg TE Parham WB Baze G Suarez JW Peterson AK Chopra 2009 Characterization of the rat pneumonic plague model: infection kinetics following aerosolization of Yersinia pestis CO92 Microbes Infect 11 205 214 1:CAS:528:DC%2BD1MXivVWgsL0%3D
5. CL Airharta HN Rohdea CJ Hovdea GA Bohacha CF Deobalda SS Leeb SA Minnich 2008 Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine Vaccine 26 5554 5561
6. Alibek K, Handelman S (2000) Biohazard: the chilling true story of the largest covert biological weapons program in the world-told from inside by the man who ran it. Random House, New York
7. ML Alvarez GA Cardineau 2010 Prevention of bubonic and pneumonic plague using plant-derived vaccines Biotechnol Adv 28 184 196 1:CAS:528: DC%2BD1MXhsFGrtL3L
8. ML Alvarez HL Pinyerd E Topal GA Cardineau 2008 P19-dependent and P19-independent reversion of F1-V gene silencing in tomato Plant Mol Biol 68 61 79 1:CAS:528:DC%2BD1cXptVGltbY%3D
9. ML Alvarez E Topal F Martin GA Cardineau 2010 Higher accumulation of F1-V fusion recombinant protein in plants after induction of protein body formation Plant Mol Biol 72 75 89 1:CAS:528:DC%2BD1MXhsV2mtb%2FM
10. K Amemiya JL Meyers TE Rogers RL Fast AD Bassett PL Worshama BS Powell SL Norris AM Krieg JJ Adamovicz 2009 CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague Vaccine 27 2220 2229 1:CAS:528:DC%2BD1MXjtF2mt7k%3D
11. GP Andrews ST Strachan GE Benner AK Sample GW Anderson Jr JJ Adamovicz SL Welkos JK Pullen AM Friedlander 1999 Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis Infect Immun 67 1533 1537 1:CAS:528: DyaK1MXhsFelsrg%3D (Pubitemid 29108541)
12. PA Arlen M Singleton JJ Adamovicz Y Ding A Davoodi-Semiromi H Daniell 2008 Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts Infect Immun 76 3640 3650 1:CAS:528: DC%2BD1cXptF2iurY%3D
13. J Bashaw S Norris S Weeks S Trevino JJ Adamovicz S Welkos 2007 Development of in vitro correlate assays of immunity to infection with Yersinia pestis Clin Vaccine Immunol 14 605 616 1:CAS:528:DC%2BD2sXlslSmsb8%3D
14. D Bhattacharya J Mecsas LT Hu 2010 Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis Vaccine 28 7683 7689 1:CAS:528:DC%2BC3cXhsVWmtbjJ
15. T Blisnick P Ave M Huerre E Carniel CE Demeure 2008 Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain Infect Immun 76 83808 83816
16. J Bozue S Mou KL Moody CK Cote S Trevino D Fritz P Worsham 2011 The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis Microb Pathog 50 314 321 1:CAS:528:DC%2BC3MXlsFKgurg%3D
17. JL Boyer C Sofer-Podesta J Ang NR Hackett MJ Chiuchiolo S Senina D Perlin RG Crystal 2010 Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid Hum Gene Ther 21 891 901 1:CAS:528:DC%2BC3cXosFartr0%3D
18. CG Branger W Sun A Torres-Escobar R Perry KL Roland J Fetherston R Curtiss III 2010 Evaluation of Psn HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge Vaccine 29 274 282 1:CAS:528:DC%2BC3cXhsFajt7vE
19. CG Branger A Torres-Escobar W Sun R Perry J Fetherston KL Roland R Curtiss III 2009 Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica Vaccine 27 5363 5370 1:CAS:528:DC%2BD1MXpvF2rsbk%3D
20. JN Brewoo TD Powell DT Stinchcomb JE Osorio 2010 Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice Vaccine 28 5891 5899 1:CAS:528:DC%2BC3cXhtVaqurfK
21. RR Brubaker ED Beesley MJ Surgalla 1965 Pasteurella pestis: role of pesticin I and iron in experimental plague Science 149 422 424 1:CAS:528:DyaF2MXks1Gktro%3D
22. B Carrillo-Conde E Schiltz J Yu FC Minion GJ Phillips MJ Wannemuehler B Narasimhan 2010 Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens Acta Biomater 6 3110 3119 1:CAS:528:DC%2BC3cXpslOrt78%3D
23. JS Cathelyn SD Crosby WW Lathem WE Goldman VL Miller 2006 RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague Proc Natl Acad Sci 103 13514 13519 1:CAS:528:DC%2BD28XpvVeqt7w%3D (Pubitemid 44380139)
24. PS Chain E Carniel FW Larimer J Lamerdin PO Stoutland WM Regala AM Georgescu LM Vergez ML Land VL Motin RR Brubaker J Fowler J Hinnebusch M Marceau C Medigue M Simonet V Chenal-Francisque B Souza D Dacheux JM Elliott A Derbise LJ Hauser E Garcia 2004 Insights into the evolution of Yersinia pestis through whole genome comparison with Yersinia pseudotuberculosis Proc Natl Acad Sci 101 13826 13831 1:CAS:528:DC%2BD2cXotVygtLY%3D (Pubitemid 39298492)
25. A Chattopadhyaya S Park G Delmas R Suresh S Senina DS Perlin JK Rose 2008 Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection Vaccine 26 6329 6337
26. TH Chen KF Meyer 1974 Susceptibility and antibody response of Rattus species to experimental plague J Infect Dis 129 Suppl S53 S61
27. JA Chichester K Musiychuk CE Farrance V Mett J Lyons V Mett Y Yusibov 2009 A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague Vaccine 27 3471 3474 1:CAS:528:DC%2BD1MXmtlKnsrk%3D
28. MJ Chiuchiolo JL Boyer A Krause S Senina NR Hackett RG Crystal 2006 Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen J Infect Dis 194 1249 1257 1:CAS:528:DC%2BD28Xht1eiu7fF (Pubitemid 44630970)
29. GR Cornelis F Van Gijsegem 2000 Assembly and function of type III secretory systems Ann Rev Microbiol 54 735 774 1:CAS:528:DC%2BD3cXotFWrsLc%3D
30. CA Cornelius LE Quenee KA Overheim F Koster TL Brasel D Elli NA Ciletti O Schneewind 2008 Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague Infect Immun 76 5588 5597 1:CAS:528: DC%2BD1cXhsVOgs77K
31. JF Cully Jr ES Williams 2001 Interspecific comparisons of sylvatic plague in prairie dogs J Mammal 82 894 905 (Pubitemid 33146155)
32. KJ Davis DL Fritz ML Pitt SL Welkos PL Worsham AM Friedlander 1996 Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops) Arch Pathol Lab Med 120 156 163 1:STN:280:DyaK287pslOrsw%3D%3D (Pubitemid 26058523)
33. Dean P (2011) Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol Rev. doi: 10.1111/j.1574-6976.2011.00271.x
34. G Del Prete L Santi V Andrianaivoarimanana A Amedei O Domarle MM D' Elios CJ Arntzen L Rahalison HS Mason 2009 Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system Int J Immunopathol Pharmacol 22 133 143
35. B del Rio JL Fuente V Neves R Dattwyler JF Seegers M Gomes-Solecki 2010 Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis Vaccine 28 6714 6722
36. W Deng V Burland G Plunkett 3rd A Boutin GF Mayhew P Liss NT Perna DJ Rose B Mau S Zhou DC Schwartz JD Fetherston LE Lindler RR Brubaker GV Plano SC Straley KA McDonough ML Nilles JS Matson FR Blattner RD Perry 2002 Genome sequence of Yersinia pestis KIM J Bacteriol 184 4601 4611 1:CAS:528: DC%2BD38XlvV2gsL0%3D (Pubitemid 34832588)
37. Y Do H Koh CG Park D Dudziak P Seo S Mehandru JH Choi C Cheong S Park DS Perlin BS Powell RM Steinman 2010 Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague Eur J Immunol 40 2791 2796 1:CAS:528:DC%2BC3cXhsVGhtrvF
38. JE Donavan D Ham GM Fukui MJ Surgalla 1961 Role of the capsule of Pasterella pestis in bubonic plague in the guinea pig J Infect Dis 109 154 157 1:STN:280:DyaF38%2FivVGjtQ%3D%3D
39. Y Du R Rosqvist A Forsberg 2002 Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis Infect Immun 70 1453 1460 1:CAS:528:DC%2BD38XhsFSlsbY%3D (Pubitemid 34163423)
40. D Dulebohn J Choy T Sundermeier N Okan AW Karzai 2007 Trans-translation: the tmRNA-mediated surveillance mechanism for ribosome rescue, directed protein degradation, and nonstop mRNA decay Biochemistry 46 4681 4693 1:CAS:528:DC%2BD2sXjs1SktLk%3D (Pubitemid 46651192)
41. RG Evans JM Crutcher B Shadel B Clements MS Bronze 2002 Terrorism from a public health perspective Am J Med Sci 323 291 298 (Pubitemid 34657231)
42. AA Fadl J Sha GR Klimpel JP Olano DW Niesel AK Chopra 2005 Murine lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar Typhimurium systemic infection Infect Immun 73 1081 1096 1:CAS:528:DC%2BD2MXhtVWgs7o%3D (Pubitemid 40165769)
43. AA Fadl J Sha GR Klimpel JP Olano CL Galindo AK Chopra 2005 Attenuation of Salmonella enterica serovar Typhimurium by altering biological functions of murine lipoprotein and lipopolysaccharide Infect Immun 73 8433 8436 1:CAS:528:DC%2BD2MXhtlertr3F (Pubitemid 41740338)
44. VA Feodorova LN Pan'kina EP Savostina LV Sayapina VL Motin SV Dentovskaya RZ Shaikhutdinova SA Ivanov B Lindner AN Kondakova OV Bystrova NA Kocharova SN Senchenkova O Holst GB Pier YA Knirel AP Anisimov 2007 A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs Vaccine 25 7620 7628 1:CAS:528:DC%2BD2sXhtFKhs7bN (Pubitemid 47538817)
45. VA Feodorova LN Pan'kina EP Savostina OS Kuznetsov NP Konnov LV Sayapina SV Dentovskaya RZ Shaikhutdinova SA Ageev B Lindner AN Kondakova OV Bystrova NA Kocharova SN Senchenkova O Holst GB Pier YA Knirel AP Anisimov VL Motin 2009 Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens Vaccine 27 2240 2250 1:CAS:528:DC%2BD1MXjtF2mtLw%3D
46. DM Ferber RR Brubaker 1979 Mode of action of pesticin: N-acetylglucosaminidase activity J Bacteriol 139 495 501 1:CAS:528: DyaE1MXlvVynur4%3D (Pubitemid 9225583)
47. AA Filippov NS Solodovnikov LM Kookleva OA Protsenko 1990 Plasmid content in Yersinia pestis strains of different origin FEMS Microbiol Lett 55 45 48 1:STN:280:DyaK3c3ivVOrug%3D%3D (Pubitemid 20066041)
48. AM Friedlander SL Welkos PL Worsham GP Andrews DG Heath GW Anderson Jr ML Pitt JE Step K Davis 1995 Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis Clin Infect Dis 21 Suppl 2 S178 S181
49. JE Galen J Nair JY Wang SS Wasserman MK Tanner MB Sztein MM Levine 1999 Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA Infect Immun 67 6424 6433 1:CAS:528: DyaK1MXns1ylu7w%3D
50. M Galimand A Guiyoule G Gerbaud B Rasoamanana S Chanteau E Carniel P Courvalin 1997 Multidrug resistance in Yersinia pestis mediated by a transferable plasmid New Eng J Med 337 677 680 1:CAS:528:DyaK2sXmt1WqtbY%3D (Pubitemid 27375474)
51. CL Galindo ST Moen EV Kozlova J Sha HR Garner SL Agar AK Chopra 2009 Comparative analyses of transcriptional profiles in mouse organs in a pneumonic plague model after infection with wild-type Yersinia pestis CO92 and its Braun lipoprotein mutant Comp Funct Genomics 2009 914762
52. CL Galindo J Sha ST Moen SL Agar ML Kirtley SM Foltz LJ McIver EV Kozlova HR Garner AK Chopra 2010 Comparative global gene expression profiles of wild-type Yersinia pestis CO92 and its Braun lipoprotein mutant at flea and human body temperatures Comp Funct Genomics 2010 342168
53. EM Galvan MK Mohan Nair H Chen F Del Piero DM Schifferli 2010 Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa Infect Immun 78 3443 3453 1:CAS:528:DC%2BC3cXhtVeisLrP
54. I Gendlina KG Held SS Bartra BM Gallis CE Doneanu DR Goodlett GV Plano CM Collins 2007 Identification and type III-dependent secretion of the Yersinia pestis insecticidal-like proteins Mol Microbiol 64 1214 1227 1:CAS:528:DC%2BD2sXmslyju7k%3D (Pubitemid 46849013)
55. JL Goodin BS Powell JT Enama RW Raab RL McKown GL Coffman GP Andrews 2010 Purification and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague Protein Expr Purif 76 136 144
56. RA Greenfield DA Drevets LJ Machado GW Voskuhl P Cornea MS Bronze 2002 Bacterial pathogens as biological weapons and agents of bioterrorism Am J Med Sci 323 299 315 (Pubitemid 34651568)
57. A Guiyoule G Gerbaud C Buchrieser M Galimand L Rahalison S Chanteau P Courvalin E Carniel 2001 Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis Emerg Infect Dis 7 43 48 1:CAS:528:DC%2BD3MXhsFGltLc%3D (Pubitemid 32173332)
58. G Gupta AA Khan DN Rao 2010 Cell-mediated immune response and Th1/Th2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis Scand J Immunol 71 186 198 1:CAS:528:DC%2BC3cXjvFCrt7s%3D
59. DL Heymann 2005 Emerging and re-emerging infectious diseases from plague and cholera to Ebola and AIDS: a potential for international spread that transcends the defenses of any single country J Contig Crisis Manag 13 29
60. J Hill S Leary S Smither A Besta J Pettersson A Forsberg B Lingard A Lipka KA Brown ED Williamson RW Titball 2009 N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection Vaccine 27 7073 7079 1:CAS:528:DC%2BD1MXhtlCnt7jN
61. BJ Hinnebusch ER Fischer TG Schwan 1998 Evaluation of the role of the Yersinia pestis plasminogen activator and other plasmid-encoded factors in temperature-dependent blockage of the flea J Infect Dis 178 1406 1415 1:CAS:528:DyaK1cXns1Ogt7w%3D
62. XZ Huang MP Nikolich LE Lindler 2006 Current trends in plague research: from genomics to virulence Clin Med Res 4 189 199 1:CAS:528:DC%2BD28XhtFeitb%2FL (Pubitemid 44496012)
63. J Huang AJ D'Souza JB Alarcon JA Mikszta BM Ford MS Ferriter M Evans T Stewart K Amemiya RG Ulrich VJ Sullivan 2009 Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine Clin Vaccine Immunol 16 719 725 1:CAS:528:DC%2BD1MXotV2ju78%3D
64. TV Inglesby DT Dennis DA Henderson JG Bartlett MS Ascher E Eitzen AD Fine AM Friedlander J Hauer JF Koerner M Layton J McDade MT Osterholm T O'Toole G Parker TM Perl PK Russell M Schoch-Spana K Tonat 2000 Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense JAMA 283 2281 2290 1:STN:280:DC%2BD3c3msFKluw%3D%3D (Pubitemid 30246781)
65. MI Ivanov BL Noel R Rampersaud P Mena JL Benach JB Bliska 2008 Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1 Yersinia pestis Infect Immun 76 5181 5190 1:CAS:528:DC%2BD1cXhtlajtrbF
66. E Jawetz KF Meyer 1944 The behavior of virulent and avirulent P. pestis in normal and immune experimental animals J Infect Dis 74 1
67. SM Jones KF Griffin I Hodgson ED Williamson 2003 Protective efficacy of a fully recombinant plague vaccine in the guinea pig Vaccine 21 3912 3918 1:CAS:528:DC%2BD3sXmt1Gku74%3D (Pubitemid 37338218)
68. A Jones C Bosioa A Duffy A Goodyear M Schriefer S Dow 2010 Protection against pneumonic plague following oral immunization with a non-replicating vaccine Vaccine 28 5924 5929 1:CAS:528:DC%2BC3cXhtVaqurfF
69. AW Karzai ED Roche RT Sauer 2000 The SsrA-SmpB system for protein tagging, directed degradation and ribosome rescue Nat Struct Biol 7 449 455 1:CAS:528:DC%2BD3cXktFantr8%3D (Pubitemid 30414463)
70. K Kawahara H Tsukano H Watanabe B Lindner M Matsuura 2002 Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature Infect Immun 70 4092 4098 1:CAS:528:DC%2BD38XlsFCmsb8%3D (Pubitemid 34790917)
71. KC Keiler 2008 Biology of trans-translation Annu Rev Microbiol 62 133 151 1:CAS:528:DC%2BD1cXht1Gls7zI
72. TJ Kim S Chauhan VL Motin EB Goh MM Igo GM Young 2007 Direct transcriptional control of the plasminogen activator gene of Yersinia pestis by the cyclic AMP receptor protein J Bacteriol 189 8890 8900 1:CAS:528: DC%2BD1cXjtVc%3D
73. R Kingston F Burke JH Robinson PA Bedford SM Jones SC Knight ED Williamson 2007 The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses Clin Exp Immunol 149 561 569 1:CAS:528:DC%2BD2sXhtFSlurrF (Pubitemid 47256165)
74. AM Kolodziejek DR Schnider HN Rohde AJ Wojtowicz GA Bohach SA Minnich CJ Hovde 2010 Outer membrane protein X (Ail) contributes to Yersinia pestis virulence in pneumonic plague and its activity is dependent on LPS core length Infect Immun 78 5233 5243 1:CAS:528:DC%2BC3MXhtlCnsrg%3D
75. F Koster DS Perlin S Park T Brasel A Gigliotti E Barr L Myers RC Layton R Sherwood CR Lyons 2010 Milestones in progression of primary pneumonic plague in cynomolgus macaques Infect Immun 78 2946 2955 1:CAS:528:DC%2BC3cXpvVOgtLk%3D
76. WW Lathem PA Price VL Miller WE Goldman 2007 A plasminogen-activating protease specifically controls the development of primary pneumonic plague Science 315 509 513 1:CAS:528:DC%2BD2sXotFCisw%3D%3D (Pubitemid 46175753)
77. Lawal A, Jejelowo O, Chopra AK, Rosenzweig JA (2010) Ribonucleases and bacterial virulence (minireview). Microbial Biotech. doi: 1111/j.1751-7915.2010. 00212X
78. BL Ligon 2006 Plague: a review of its history and potential as a biological weapon Semin Pediatr Infect Dis 17 161 170 (Pubitemid 44278622)
79. SF Little WM Webster H Wilhelm D Fisher SLW Norris BS Powell J Enama JJ Adamovicz 2010 Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice Vaccine 28 934 939 1:CAS:528:DC%2BC3cXntlSmtg%3D%3D
80. T Liu R König J Sha SL Agar CT Tseng GR Klimpel AK Chopra 2008 Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines Microb Pathog 44 224 237 (Pubitemid 351163529)
81. T Liu SL Agar J Sha AK Chopra 2010 Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: role of Lpp in modulating NF-kB activation and host cell death Microb Pathog 48 42 52 1:CAS:528: DC%2BD1MXhs1Wjt7vM
82. KA McDonough AM Barnes TJ Quan J Montenieri S Falkow 1993 Mutation in the pla gene of Yersinia pestis alters the course of the plague bacillus-flea (Siphonaptera: Ceratophyllidae) interaction J Med Entomol 30 772 780 1:CAS:528:DyaK2MXpvVKm
83. SB Mizel AH Graff N Sriranganathan S Ervin CJ Lees MO Lively RR Hantgan MJ Thomas J Wood B Bell 2009 Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates Clin Vaccine Immunol 16 21 28 1:CAS:528:DC%2BD1MXht1SksLw%3D
84. SW Montminy N Khan S McGrath MJ Walkowicz F Sharp JE Conlon K Fukase S Kusumoto C Sweet K Miyake S Akira RJ Cotter JD Goguen E Lien 2006 Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response Nat Immunol 7 1066 1073 1:CAS:528:DC%2BD28Xps1ynur8%3D (Pubitemid 44420651)
85. BS Murphy CR Wulff BA Garvy SC Straley 2007 Yersinia pestis YadC: a novel vaccine candidate against plague Adv Exp Med Biol 603 400 414
86. NA Okan P Mena JL Benach JB Bliska AW Karzail 2010 The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague Infection Infect Immun 78 1284 1293 1:CAS:528:DC%2BC3cXjtFaitro%3D
87. PC Oyston N Dorrell K Williams SR Li M Green RW Titball BW Wren 2000 The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis Infect Immun 68 3419 3425 1:CAS:528:DC%2BD3cXjsF2js7w%3D (Pubitemid 30340439)
88. PCF Oyston G Mellado-Sanchez MF Pasetti JP Nataro RW Titball HS Atkins 2010 A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection Microb Pathog 48 191 195 1:CAS:528:DC%2BC3cXkvFKrs7Y%3D
89. J Parkhill BW Wren NR Thomson RW Titball MT Holden MB Prentice M Sebaihia KD James C Churcher KL Mungall S Baker D Basham SD Bentley K Brooks AM Cerdeño-Tárraga T Chillingworth A Cronin RM Davies P Davis G Dougan T Feltwell N Hamlin S Holroyd K Jagels AV Karlyshev S Leather S Moule PC Oyston M Quail K Rutherford M Simmonds J Skelton K Stevens S Whitehead BG Barrell 2001 Genome sequence of Yersinia pestis, the causative agent of plague Nature 413 523 527 1:CAS:528:DC%2BD3MXnsFygurc%3D (Pubitemid 32938750)
90. Pearson GS (1998) The threat of deliberate disease in the 21st century. Henry L. Stimson Centre report no. 24. Biological weapons proliferation: reasons for concern, courses of action. Available from: http://www.brad.ac.uk/acad/ sbtwc/other/disease.htm
91. RD Perry JD Fetherson 1997 Yersinia pestis-etiological agent of plague Clin Microbiol Rev 10 35 66 1:CAS:528:DyaK2sXotlSqtw%3D%3D
92. 2+-response plasmid pCD1 of Yersinia pestis KIM5 Infect Immun 66 4611 4623 1:CAS:528:DyaK1cXmsV2murk%3D (Pubitemid 28453060)
93. JW Peterson KG Walberg J Pawlik K Bush J Taormina J Hardcastle S Moen J Thomas W Lawrence C Ponce T Parham BM Chatuev L Sower G Klimpel T Eaves-Pyles AK Chopra 2010 Evaluation of protection afforded by fluoroquinolones against respiratory infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis Open Microbiology Journal 4 34 46 1:CAS:528:DC%2BC3cXotV2hsrc%3D
94. K Pouliot N Pan S Wang S Lu E Lien JD Goguen 2007 Evaluation of the role of LcrV-toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis Infect Immun 75 3571 3580 1:CAS:528:DC%2BD2sXptV2ktrY%3D (Pubitemid 47040960)
95. Z Qia L Zhou Q Zhanga L Ren R Daia B Wuc T Wang Z Zhu Y Yang B Cuia Z Wanga H Wang Y Qiu Z Guo R Yang X Wang 2010 Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1 + rV270 Vaccine 28 1655 1660
96. Y Qiu Y Liu Z Qi W Wang Z Kou Q Zhang G Liu T Liu Y Yang X Yang Y Xin C Li B Cui S Huang H Liu L Zeng Z Wang R Yang H Wang X Wang 2010 Comparison of immunological responses of plague vaccines F1 + rV270 and EV76 in chinese-origin rhesus macaque, Macaca mulatta Scand J Immunol 72 425 433 1:CAS:528: DC%2BC3cXhsVagtLzO
97. LE Quenee CA Cornelius NA Ciletti D Elli O Schneewind 2008 Yersinia pestis caf1 variants and the limits of plague vaccine protection Infect Immun 76 2025 2036 1:CAS:528:DC%2BD1cXltlektbk%3D (Pubitemid 351656135)
98. LE Quenee BJ Berube J Segal D Elli NA Ciletti D Anderson O Schneewind 2010 Amino acid residues 196-225 of LcrV represent a plague protective epitope Vaccine 28 1870 1876 1:CAS:528:DC%2BC3cXhs1GqsLg%3D
99. K Ramirez AVE Capozzo SA Lloyd MB Sztein JP Nataro MF Pasetti 2009 Mucosally delivered Salmonella Typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost J Immunol 182 1211 1222 1:CAS:528:DC%2BD1MXhsVKrtw%3D%3D
100. K Ramirez Y Ditamo L Rodriguez WL Picking ML van Roosmalen K Leenhouts MF Pasetti 2010 Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection Mucosal Immunol 3 159 171 1:CAS:528:DC%2BC3cXhvVGqu7s%3D
101. D Reithmeier-Rost J Hill SJ Elvin D Williamson S Dittmann A Schmid G Wilharm A Sing 2007 The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis Microbes Infect 9 997 1002 1:CAS:528:DC%2BD2sXmvVOgu7o%3D (Pubitemid 46929098)
102. J Ren D Dong J Zhang J Zhang S Liu B Li L Fu J Xu C Yu L Hou J Li W Chen 2009 Protection against anthrax and plague by a combined vaccine in mice and rabbits Vaccine 27 7436 7441 1:CAS:528:DC%2BD1MXhsFShurvN
103. S Riedel 2005 Plague: from natural disease to bioterrorism BUMC Proc 18 116 124
104. MM Rigano C Manna A Giulini A Vitale T Cardi 2009 Plants as biofactories for the production of subunit vaccines against bio-security-related bacteria and viruses Vaccine 27 3463 3466 1:CAS:528:DC%2BD1MXmtlKnsrs%3D
105. TE Rocke SR Smith DT Stinchcom JE Osorio 2008 Immunization of black-tailed prairie dog against plague through consumption of vaccine-laden baits J Wildl Dis 44 930 937
106. TE Rocke KP Iams S Dawe SR Smith JL Williamson DM Heisey JE Osorio 2010 Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis) Vaccine 28 338 344
107. TE Rocke N Pussini SR Smith J Williamson B Powell JE Osorio 2010b Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus) Vector Borne Zoonotic Dis 10 53 58
108. S Rosales-Mendoza RE Soria-Guerra L Moreno-Fierros AG Alpuche-Solis L Martinez-Gonzalez SS Korban 2010 Expression of an immunogenic F1-V fusion protein in lettuce as a plant-based vaccine against plague Planta 232 409 416 1:CAS:528:DC%2BC3cXnsFGrur0%3D
109. S Rosales-Mendoza RE Soria-Guerra L Moreno-Fierros Y Han AG Alpuche-Solís SS Korban 2010 Transgenic carrot tap roots expressing an immunogenic F1-V fusion protein from Yersinia pestis are immunogenic in mice J Plant Physiol 168 174 180
110. JA Rosenzweig G Weltman GV Plano K Schesser 2005 Modulation of Yersinia's type three secretion system by the S1 domain of polynucleotide phosphorylase J Biol Chem 7 280 156
111. JA Rosenzweig B Chromy A Echeverry J Yang B Adkins GV Plano S McCutchen-Maloney K Schesser 2007 Polynucleotide phosphorylase independently controls virulence factor expression levels and export in the yersiniae FEMS Microbiol Lett 270 255 264 1:CAS:528:DC%2BD2sXkvFSrsrg%3D (Pubitemid 46597373)
112. - strains of Yersinia pestis for guinea-pigs J Med Microbiol 45 440 444 1:STN:280:DyaK2s7hslWkug%3D%3D (Pubitemid 26397969)
113. F Sebbane D Gardner D Long BB Gowen BJ Hinnebusch 2005 Kinetics of disease progression and host response in a rat model of bubonic plague Am J Pathol 166 1427 1439 (Pubitemid 40586513)
114. F Sebbane CO Jarrett D Gardner D Long BJ Hinnebusch 2006 Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague Proc Natl Acad Sci 103 5526 5530 1:CAS:528:DC%2BD28Xjslejs7s%3D
115. J Sha AA Fadl GR Klimpel DW Niesel VL Popov AK Chopra 2004 The two murine lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism Infect Immun 72 3987 4003 1:CAS:528: DC%2BD2cXlslWis7o%3D (Pubitemid 38821914)
116. J Sha L Pillai AA Fadl TE Erova CL Galindo AK Chopra 2005 The type III secretion system and cytotoxic enterotoxin alter the virulence of Aeromonas hydrophila Infect Immun 73 6446 6457 1:CAS:528:DC%2BD2MXhtVyhurvJ (Pubitemid 41368806)
117. J Sha SL Agar WB Baze JP Olano AA Fadl TE Erova S Wang SM Foltz G Suarez VL Motin S Chauhan GR Klimpel JW Peterson AK Chopra 2008 Braun lipoprotein (Lpp) contributes to the virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague Infect Immun 76 1390 1409 1:CAS:528: DC%2BD1cXksFWrsLg%3D (Pubitemid 351561984)
118. J Sha JJ Endsley ML Kirtley SM Foltz MB Huante TE Erova EV Kozlova VL Popov LA Yeager IV Zudina VL Motin JW Peterson AK Chopra 2011 Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of the sensitivity and specificity of F1 antigen capture-based dipsticks J Clin Microbiol 49 1708 1715
119. M Simonet P Berche D Mazigh M Veron 1985 Protection against Yersina infection induced by non-virulence-plasmid-encoded antigens J Med Microbiol 20 225 231 1:STN:280:DyaL28%2FhtFCksg%3D%3D (Pubitemid 16223027)
120. ST Smiley 2008 Current challenges in the development of vaccines for pneumonic plague Expert Rev Vaccines 7 209 221 1:CAS:528:DC%2BD1cXjtFOgtbw%3D (Pubitemid 351357956)
121. ST Smiley 2008 Immune defense against pneumonic plague Immunol Rev 225 256 271 1:CAS:528:DC%2BD1cXht1CmtbnJ
122. OA Sodeinde YV Subrahmanyam K Stark T Quan Y Bao JD Goguen 1992 A surface protease and the invasive character of plague Science 258 1004 1007 1:CAS:528:DyaK3sXkvFSl
123. C Sofer-Podesta J Ang NR Hackett S Senina D Perlin RG Crystal JL Boyer 2009 Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge Infect Immun 4 1561 1568
124. SC Straley RR Brubaker 1982 Localization in Yersinia pestis of peptides associated with virulence Infect Immun 36 129 135 1:CAS:528:DyaL38XitFeqs70%3D (Pubitemid 12156415)
125. F Suleyman TM Tsang ES Krukonis 2010 Three Yersinia pestis adhesins facilitate Yop delivery to eukaryotic cells and contribute to plague virulence Infect Immun 78 4134 4150
126. W Sun KL Roland CG Branger X Kuang R Curtiss III 2009 The role of relA and spoT in Yersinia pestis KIM5+ pathogenicity PLoS One 4 8 e6720 10.1371/journal.pone.0006720
127. W Sun KL Roland X Kuang CG Branger R Curtiss III 2010 Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague Infect Immun 78 1304 1313 1:CAS:528:DC%2BC3cXjtFaitrg%3D
128. W Sun D Six X Kuang KL Roland CRH Raetz R Curtiss III 2011 A live attenuated strain of Yersinia pestis KIM as a vaccine against plague Vaccine 29 2986 2998 1:CAS:528:DC%2BC3MXkt1akt7k%3D
129. M Suomalainen J Haiko P Ramu L Lobo M Kukkonen B Westerlund-Wikström R Virkola K Lähteenmäki TK Korhonen 2007 Using every trick in the book: the Pla surface protease of Yersinia pestis Adv Exp Med Biol 603 268 278
130. FM Szaba LW Kummer LB Wilhelm JS Lin MA Parent SW Montminy-Paquette E Lien LL Johnson ST Smiley 2008 D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague Infect Immun 77 4295 4304
131. VL Taylor RW Titball PCF Oyston 2005 Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague Microbiology 151 1919 1926 1:CAS:528:DC%2BD2MXlslertbY%3D (Pubitemid 40909034)
132. RJ Thomas D Webber A Collinge AJ Stagg SC Bailey A Nunez A Gates PN Jayasekera RR Taylor S Eley RW Titball 2009 Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols Infect Immun 77 315 1323
133. A Tidhar Y Flashner S Cohen Y Levi A Zauberman D Gur M Aftalion E Elhanany A Zvi A Shafferman E Mamroud 2009 The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague PLoS One 4 9 e7023
134. RW Titball ED Williamson 2004 Yersinia pestis (plague) vaccines Expert Opin Biol Ther 4 965 973 1:CAS:528:DC%2BD2cXksVaqtLY%3D (Pubitemid 38843233)
135. A Torres-Escobar MD Juárez-Rodríguez R Curtiss III 2009 Biogenesis of Yersinia pestis PsaA in recombinant attenuated Salmonella Typhimurium vaccine (RASV) strain FEMS Microbiol Lett 302 106 113
136. A Torres-Escobar MD Juárez-Rodríguez CG Branger R Curtiss III 2010 Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA Vaccine 27 5363 5370
137. A Torres-Escobar MD Juárez-Rodríguez BM Gunn CG Branger SA Tinge R Curtiss III 2010 Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enteric serovar Typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice Infect Immun 78 2529 2543 1:CAS:528:DC%2BC3cXnsV2jsLw%3D
138. JB Uppada AA Khan EA Bhat R Deshmukh DN Rao 2009 Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles Med Microbiol Immunol 198 247 256 1:CAS:528:DC%2BD1MXhtlantr7I
139. TJ Van Blarcom C Sofer-Podesta J Ang JL Boyer RG Crystal G Georgiou 2010 Affinity maturation of an anti-V antigen IgG expressed in situ through adenovirus gene delivery confers enhanced protection against Yersinia pestis challenge Gene Ther 17 913 921
140. C Vernazza B Lingard HC Flick-Smith LWJ Baillie J Hill HS Atkins 2009 Small protective fragments of the Yersinia pestis V antigen Vaccine 27 2775 2780 1:CAS:528:DC%2BD1MXkslOhsLY%3D
141. GI Viboud JB Bliska 2005 Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis Annu Rev Microbiol 59 69 89 1:CAS:528:DC%2BD2MXht1Shs7bL (Pubitemid 41507424)
142. A Wake H Morita M Wake 1978 Mechanisms of long and short term immunity to plague Immunology 34 1045 1052 1:STN:280:DyaE1c3ktVOguw%3D%3D (Pubitemid 8340396)
143. S Wang S Oshi I Mboudjeka F Liu T Ling JD Goguen S Lu 2008 Relative immunogenicity and protection potential of candidate Yersinia pestis antigens against lethal mucosal plague challenge in Balb/c mice Vaccine 26 1664 1674 1:CAS:528:DC%2BD1cXivFyrs7o%3D
144. S Wang I Mboudjeka JD Goguen S Lu 2010 Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines Vaccine 28 2011 2019 1:CAS:528:DC%2BC3cXisFKisLo%3D
145. Z Wang L Zhou Z Qi Q Zhang R Dai Y Yang B Cui H Wang R Yang X Wang 2010 Long-term observation of subunit vaccine F1-rV270 against Yersinia pestis in mice Clin Vaccine Immunol 17 199 201 1:CAS:528:DC%2BC3cXnsF2hsA%3D%3D
146. R Warren H Lockman R Barnewall R Krile OB Blanco D Vasconcelos J Price RV House MA Bolanowksi P Fellows 2011 Cynomolgus macaque model for pneumonic plague Microb Pathog 50 12 22 1:CAS:528:DC%2BC3MXhtF2ltQ%3D%3D
147. NE Wayson C McMahon FM Prince 1946 An evaluation of three plague vaccines against infection in guinea pigs induced by natural and artificial methods Public Health Rep 61 1511 1518 1:STN:280:DyaH2s%2FmtVWjug%3D%3D
148. EH Weening JS Cathelyn G Kaufman MB Lawrenz P Price WE Goldman VL Miller 2011 Dependence of Y. pestis capsule for pathogenesis is influenced by mouse background Infect Immun 79 644 652 1:CAS:528:DC%2BC3MXisVOrsLw%3D
149. SL Welkos KM Davis LM Pitt PL Worsham AM Freidlander 1995 Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis Contrib Microbiol Immunol 13 299 305 1:CAS:528: DyaK28Xit1Crsbs%3D
150. SL Welkos AM Friedlander KJ Davis 1997 Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain CO92 Microb Pathog 23 211 223 1:CAS:528:DyaK2sXns1ymt7g%3D (Pubitemid 27448524)
151. S Welkos ML Pitt M Martinez A Friedlander P Vogel R Tammariello 2002 Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague Vaccine 20 2206 2214 1:CAS:528:DC%2BD38XjsFOis78%3D (Pubitemid 34497029)
152. RC Williams Jr H Gewurz PG Quie 1972 Effects of fraction I from Yersinia pestis on phagocytosis in vitro J Infect Dis 126 235 241
153. ED Williamson 2001 Plague vaccine research and development J Appl Microbiol 91 606 608 1:STN:280:DC%2BD3MrjtVemug%3D%3D (Pubitemid 32948382)
154. ED Williamson HC Flick-Smith C Lebutt CA Rowland SM Jones EL Waters RJ Gwyther J Miller PJ Packer M Irving 2005 Human immune response to a plague vaccine comprising recombinant F1 and V antigens Infect Immun 73 3598 3608 1:CAS:528:DC%2BD2MXkvFCnsLo%3D (Pubitemid 40745904)
155. ED Williamson HC Flick-Smith E Waters J Miller I Hodgson CS Le Butt J Hill 2007 Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates Microb Pathog 42 11 21 1:CAS:528: DC%2BD28Xhtlaltr%2FL (Pubitemid 44932133)
156. PL Worsham MP Stein SL Welkos 1995 Construction of defined F1 negative mutants of virulent Yersinia pestis Contrib Microbiol Immunol 13 325 328 1:CAS:528:DyaK28Xit1Crtr8%3D
157. KL Wycoff A Belle D Deppe L Schaefer JM Maclean S Haase AK Trilling S Liu SH Leppla IN Geren J Pawlik JW Peterson 2011 Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax Antimicrob Agents Chemother 55 132 139 1:CAS:528: DC%2BC3MXisVehurs%3D
158. H Yamanaka T Hoyt X Yang S Golden CM Bosio K Crist T Becker M Maddaloni DW Pascual 2008 A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague Infect Immun 76 4564 4573 1:CAS:528:DC%2BD1cXhtF2jtbvF
159. H Yamanaka T Hoyt R Bowen X Yang K Crist S Golden M Maddaloni DW Pascual 2009 An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague Vaccine 27 80 87 1:CAS:528:DC%2BD1cXhsVersb%2FM
160. H Yamanaka T Hoyt X Yang R Bowen S Golden K Crist T Becker M Maddaloni DW Pascual 2010 A parenteral DNA vaccine protects against pneumonic plague Vaccine 28 3219 3230 1:CAS:528:DC%2BC3cXjvF2qs7Y%3D
161. A Zauberman A Tidhar Bar-Haim E LevyY G Halperin Y Flashner S Cohen A Shafferman E Mamroud 2009 Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague PLoS One 4 6 e5938
162. G Zeng J Chen L Zhong R Wang L Jiang J Cai L Yan D Huang CY Chen ZW Chen 2009 NSOM- and AFM-based nanotechnology elucidates nano-structural and atomic-force features of a Y. pestis V immunogen-containing particle vaccine capable of eliciting robust response Proteomics 9 538 1547
163. L Zhan Y Han L Yang J Geng Y Li H Gao Z Guo W Fan G Li L Zhang C Qin D Zhou R Yang 2008 The cyclic AMP receptor protein, CRP, is required for both virulence and expression of the minimal crp regulon in Yersinia pestis biovar microtus Infect Immun 76 5028 5037 1:CAS:528:DC%2BD1cXhtlajtrnO
164. L Zhan L Yang L Zhou Y Li H Gao Z Guo L Zhang C Qin D Zhou R Yang 2009 Direct and negative regulation of the sycO ypkA-ypoJ operon by cyclic AMP receptor protein (CRP) in Yersinia pestis BMC Microbiol 9 178
165. SS Zhang CG Park P Zhang SS Bartra GV Plano JD Klena M Skurnik BJ Hinnebusch T Chen 2008 Plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination J Biol Chem 283 31511 31521 1:CAS:528:DC%2BD1cXhtlCjsbzO
166. RA Zilinskas 2006 The anti-plague system and the Soviet biological warfare program Crit Rev Microbiol 32 47 64 (Pubitemid 43336345)